High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Recruiting
Observational Study
Critical Illness
Respiratory Failure
Multi Organ Failure
Hypoxia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- Region Stockholm · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Intubation in the intensive care unit is a standard procedure with a high risk of adverse events such as hypoxaemia and cardiovascular instability. However, it is demonstrated that HFNO (High Flow Nasal Oxygen) for pre and perioxygenation is feasible and, in many situations, prolongs the safe apnoeic period after anaesthesia induction. Previous data of the use of HFNO during intubation of the crit…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult, ≥18 years old
* Intensive care patients that require tracheal intubation for any indication
Exclusion Criteria:
* Patients with skull or facial injuries where the application of nasal cannula is to be avoided, decided by the intensivist.
* Pregnancy
* Total nasal obst…
Contacts